CY1113403T1 - Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων - Google Patents
Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειωνInfo
- Publication number
- CY1113403T1 CY1113403T1 CY20121100924T CY121100924T CY1113403T1 CY 1113403 T1 CY1113403 T1 CY 1113403T1 CY 20121100924 T CY20121100924 T CY 20121100924T CY 121100924 T CY121100924 T CY 121100924T CY 1113403 T1 CY1113403 T1 CY 1113403T1
- Authority
- CY
- Cyprus
- Prior art keywords
- monitoring
- therapies
- assessing
- evolution
- effectiveness
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20070795A FI20070795A0 (fi) | 2007-10-24 | 2007-10-24 | Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin |
| EP08842581A EP2201376B1 (en) | 2007-10-24 | 2008-10-15 | A new biomarker for monitoring development of diseases and assessing the efficacy of therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113403T1 true CY1113403T1 (el) | 2016-06-22 |
Family
ID=38656804
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121100924T CY1113403T1 (el) | 2007-10-24 | 2012-10-04 | Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων |
| CY20151100234T CY1116089T1 (el) | 2007-10-24 | 2015-03-06 | Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100234T CY1116089T1 (el) | 2007-10-24 | 2015-03-06 | Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20100209942A1 (enExample) |
| EP (2) | EP2201376B1 (enExample) |
| JP (2) | JP4982610B2 (enExample) |
| KR (2) | KR20100059902A (enExample) |
| CA (1) | CA2702635A1 (enExample) |
| CY (2) | CY1113403T1 (enExample) |
| DK (2) | DK2503338T3 (enExample) |
| ES (2) | ES2389751T3 (enExample) |
| FI (1) | FI20070795A0 (enExample) |
| HR (2) | HRP20120743T1 (enExample) |
| PL (2) | PL2503338T3 (enExample) |
| PT (2) | PT2201376E (enExample) |
| SI (2) | SI2503338T1 (enExample) |
| WO (1) | WO2009053523A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3358354B1 (en) | 2008-01-18 | 2020-07-15 | President and Fellows of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| MX382244B (es) | 2010-07-23 | 2025-03-13 | Harvard College | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales |
| CA2806293A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| EP2596349B1 (en) | 2010-07-23 | 2017-12-13 | President and Fellows of Harvard College | Methods of detecting cardiovascular diseases or conditions |
| SG10201505724SA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
| US20130203624A1 (en) | 2010-07-23 | 2013-08-08 | President And Fellows Of Harvard College | Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions |
| SG11201408383SA (en) | 2012-06-15 | 2015-01-29 | Harry Stylli | Methods of detecting diseases or conditions using circulating diseased cells |
| CN104603289A (zh) | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
| DK2956772T3 (en) * | 2013-02-14 | 2018-08-13 | Faron Pharmaceuticals Oy | A PROCEDURE FOR DETERMINING ACUTE LUNG FAILURE (ARDS) RELATED BIOMARKERS, A PROCEDURE FOR MONITORING DEVELOPMENT AND TREATMENT OF ARDS BY A PATIENT |
| EP4202441A3 (en) | 2013-03-09 | 2023-07-26 | Immunis.AI, Inc. | Gene expression profile in macrophages for the diagnosis of cancer |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| US10626464B2 (en) | 2014-09-11 | 2020-04-21 | Cell Mdx, Llc | Methods of detecting prostate cancer |
| PL3221346T3 (pl) | 2014-11-21 | 2021-03-08 | Bristol-Myers Squibb Company | Przeciwciała ze zmodyfikowanym regionem stałym łańcucha ciężkiego |
| TWI711630B (zh) | 2014-11-21 | 2020-12-01 | 美商必治妥美雅史谷比公司 | 抗ｃｄ７３抗體及其用途 |
| GB201706747D0 (en) * | 2017-04-27 | 2017-06-14 | Queen Mary | Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients |
| GB201715115D0 (en) | 2017-09-19 | 2017-11-01 | Univ London Queen Mary | Methods for assessing risk of cardiovascular disease and methods and compounds for use in treating or preventing cardiovascular disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0854934A4 (en) * | 1995-08-18 | 2000-09-06 | Donald W Landry | DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS |
| AU7310496A (en) * | 1995-10-13 | 1997-04-30 | Imperial College Of Science, Technology And Medicine | Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy |
| HUP0002003A3 (en) * | 2000-05-24 | 2003-01-28 | Pronuk Biotechnologia Kft | Process and reagent-kit for determining of 5'-nucleotidase activity |
| CA2439961A1 (en) * | 2001-03-27 | 2002-10-03 | Zymogenetics, Inc. | Human cytokine receptor |
| WO2004079013A1 (en) * | 2003-03-03 | 2004-09-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer |
| EP1608400B1 (en) * | 2003-03-28 | 2010-06-23 | Faron Pharmaceuticals OY | Elevation of adenosine level by cytokine-induced expression of cd73 |
| FI20030467A0 (fi) * | 2003-03-28 | 2003-03-28 | Sirpa Jalkanen | Menetelmä tulehdustilojen hoitamiseen |
| CN1835962A (zh) * | 2003-06-03 | 2006-09-20 | 加利福尼亚大学董事会 | 利用乙酰化二糖治疗疾病的组合物与方法 |
| ATE520979T1 (de) * | 2005-08-24 | 2011-09-15 | Bristol Myers Squibb Co | Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors |
| FI20051003A0 (fi) | 2005-10-07 | 2005-10-07 | Faron Pharmaceuticals Oy | Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi |
| EP2021350B1 (en) * | 2006-03-21 | 2016-12-21 | Rheinische Friedrich-Wilhelms-Universität Bonn | Phosphorylated a2a receptor agonists |
| CA2657576C (en) * | 2006-07-14 | 2023-10-31 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
-
2007
- 2007-10-24 FI FI20070795A patent/FI20070795A0/fi not_active Application Discontinuation
-
2008
- 2008-10-15 JP JP2010530497A patent/JP4982610B2/ja not_active Expired - Fee Related
- 2008-10-15 ES ES08842581T patent/ES2389751T3/es active Active
- 2008-10-15 CA CA2702635A patent/CA2702635A1/en not_active Abandoned
- 2008-10-15 EP EP08842581A patent/EP2201376B1/en active Active
- 2008-10-15 HR HRP20120743AT patent/HRP20120743T1/hr unknown
- 2008-10-15 SI SI200831377T patent/SI2503338T1/sl unknown
- 2008-10-15 PL PL12002502T patent/PL2503338T3/pl unknown
- 2008-10-15 ES ES12002502.8T patent/ES2532361T3/es active Active
- 2008-10-15 DK DK12002502T patent/DK2503338T3/en active
- 2008-10-15 PL PL08842581T patent/PL2201376T3/pl unknown
- 2008-10-15 WO PCT/FI2008/050576 patent/WO2009053523A1/en not_active Ceased
- 2008-10-15 KR KR1020107006430A patent/KR20100059902A/ko not_active Ceased
- 2008-10-15 US US12/679,785 patent/US20100209942A1/en not_active Abandoned
- 2008-10-15 EP EP12002502.8A patent/EP2503338B1/en active Active
- 2008-10-15 PT PT08842581T patent/PT2201376E/pt unknown
- 2008-10-15 SI SI200830723T patent/SI2201376T1/sl unknown
- 2008-10-15 KR KR1020167005473A patent/KR20160029869A/ko not_active Ceased
- 2008-10-15 PT PT12002502T patent/PT2503338E/pt unknown
- 2008-10-15 DK DK08842581.4T patent/DK2201376T3/da active
-
2012
- 2012-04-23 JP JP2012098081A patent/JP5619810B2/ja not_active Expired - Fee Related
- 2012-10-04 CY CY20121100924T patent/CY1113403T1/el unknown
-
2015
- 2015-02-16 HR HRP20150181TT patent/HRP20150181T1/hr unknown
- 2015-03-06 CY CY20151100234T patent/CY1116089T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011501176A (ja) | 2011-01-06 |
| EP2503338B1 (en) | 2014-12-24 |
| ES2389751T3 (es) | 2012-10-31 |
| PL2503338T3 (pl) | 2015-06-30 |
| CY1116089T1 (el) | 2017-02-08 |
| SI2503338T1 (sl) | 2015-06-30 |
| EP2201376A4 (en) | 2011-03-23 |
| KR20160029869A (ko) | 2016-03-15 |
| EP2503338A2 (en) | 2012-09-26 |
| JP2012159514A (ja) | 2012-08-23 |
| HRP20150181T1 (hr) | 2015-06-19 |
| WO2009053523A1 (en) | 2009-04-30 |
| JP4982610B2 (ja) | 2012-07-25 |
| KR20100059902A (ko) | 2010-06-04 |
| US20100209942A1 (en) | 2010-08-19 |
| ES2532361T3 (es) | 2015-03-26 |
| EP2201376B1 (en) | 2012-08-08 |
| PT2201376E (pt) | 2012-08-20 |
| PL2201376T3 (pl) | 2013-01-31 |
| FI20070795A0 (fi) | 2007-10-24 |
| DK2503338T3 (en) | 2015-03-09 |
| PT2503338E (pt) | 2015-03-05 |
| JP5619810B2 (ja) | 2014-11-05 |
| HRP20120743T1 (hr) | 2012-10-31 |
| EP2201376A1 (en) | 2010-06-30 |
| EP2503338A3 (en) | 2013-03-13 |
| SI2201376T1 (sl) | 2012-09-28 |
| DK2201376T3 (da) | 2012-10-15 |
| CA2702635A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116089T1 (el) | Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων | |
| EA201100965A1 (ru) | Биомаркеры для ингибиторов с антиангиогенной активностью | |
| AR098155A1 (es) | Métodos para diagnosticar y tratar trastornos eosinofílicos | |
| BR112015011359A8 (pt) | método para indicar uma presença ou não presença de câncer de próstata agressivo, dispositivo de ensaio, kit de teste, produto de programa de computador, e aparelho | |
| EA201190043A1 (ru) | Имидазопиразиновые ингибиторы syk | |
| DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
| EP1913391A4 (en) | QUANTITATIVE ASSAYS FOR PDGFR IN BODY FLUIDS | |
| CY1118377T1 (el) | Syk αναστολεις ιμιδαζοπυραζινης | |
| BRPI0906683B8 (pt) | método para medir e caracterizar microvesículas em fluidos corporais humanos | |
| BR112014002975A2 (pt) | composições de biomarcador e métodos | |
| EA200900177A1 (ru) | Замещенные ациланилиды и способы их применения | |
| CY1117817T1 (el) | Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων | |
| DE60329165D1 (de) | Detektion und/oder beobachtung von synuclein-assoziierten krankheiten | |
| NZ609493A (en) | Diagnosis and treatments relating to th2 inhibition | |
| BR112014031414A2 (pt) | métodos de detectar doenças ou condições utilizando células doentes circulantes | |
| JOP20190199B1 (ar) | استخدام العوامل الحيوية في تحديد مرضى السرطان الذين سوف يستجيبون للعلاج بمثبط prmt5 | |
| CY1115640T1 (el) | Διαγνωση και αγωγη εναντι της σχιζοφρενειας | |
| ATE531820T1 (de) | Gesundheitszustandstest | |
| CY1125388T1 (el) | Πολυπλεγμενη παραλληλη αναλυση εμπλουτισμενη σε στοχους για την αξιολογηση βιοδεικτων ογκου | |
| CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
| EP4502182A3 (en) | Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (ra) | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| BR112015021507A2 (pt) | métodos e composições para o diagnóstico de pré-eclampsia | |
| EP2245460A4 (en) | TEST SYSTEM FOR ASSESSING ONCOGENICITY, TUMOR DEVELOPMENT AND EFFICACY OF TREATMENT | |
| ATE454465T1 (de) | In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie |